Identification of biomarker patterns in a biological sample, such as serum or plasma, can dramatically increase the success of almost any drug development program. Myriad RBM's MAP approach provides investigators with a reliable platform that allows discovery, validation, and clinical use of these patterns in a cost-effective, efficient manner.
Myriad RBM's Human MAPs represent the most comprehensive menu of quantitative, multiplexed immunoassays commercially available. Our Human MAPs provide insight into multiple pathways to help better understand the underlying biology.
Please click on the following MAPs for a complete list of included analytes.
|Serum or plasma||Other fluids*|
|Human DiscoveryMAP®||650 µL||3 mL|
|Human ExplorerMAP™||300 µL||800 µL|
|HumanMAP®||150 µL||650 µL|
|Human CardiovascularMAP®||200 µL||700 µL|
|Human AngiogenesisMAP®||250 µL||500 µL|
|Human InflammationMAP®||50 µL||300 µL|
|Human ImmunoMAP®||200 µL||650 µL|
|Human NeuroMAP™||100 µL||500 µL|
|Human MetabolicMAP®||50 µL||300 µL|
|Human KidneyMAP®||50 µL||350 µL|
|Human CytokineMAP® A||50 µL||125 µL|
|Human CytokineMAP® B||50 µL||125 µL|
|Vectra® DA**||300 µL||n/a|
* Cerebrospinal fluid, urine, tissue culture supernatants, bronchoalveolar lavage, synovial fluid, tissue extracts, tears, skin washings, etc.
** Serum is the only accepted sample type for Vectra DA testing. If MAP and Vectra DA testing services are requested, please provide a separate electronic sample manifest and sample aliquot for Vectra DA testing. All Vectra DA testing is performed at Crescendo Biosciences, Inc.
If your volumes are not sufficient, please contact Myriad RBM for other options and information.
Myriad RBM is a CLIA certified laboratory that supports GLP studies. All testing is performed to the highest standards of scientific quality in accordance with our standard operating procedures and applicable regulatory requirements.
Please click here to read more about our laboratory’s quality standards and MAP validation process.